Matthew Scarpelli

Active Mentor - currently hosting PULSe students for laboratory rotations and recruiting PULSe students into the laboratory; serves on preliminary exam committees

Current Research Interests:

Area 1) Investigating the role of the immune system in the biological response to radiation. There is increasing evidence that radiotherapy stimulates the immune system through the release of tumor antigens from dead tumor cells. These antigens are recognized by the immune system, stimulating an immune response against residual tumor cells and in rare cases distant metastases through the abscopal effect. However, these responses are not fully understood and distant metastatic responses to localized radiotherapy are exceedingly rare. Investigating this phenomenon and leveraging it to improve the efficacy of radiotherapy is a guiding principle of the lab.

Area 2) Establishing imaging biomarkers of the immune system. There is no established clinical method for measuring immune responses in tumors or specific organs. Due to the dynamic nature of the immune system, conventional tissue biomarkers derived at a single timepoint (e.g., tissue biopsies), generally do not provide reliable measures of the immune system. Furthermore, conventional imaging methods, often used to track changes in tumor size, are insensitive to the immune system and its effects on the tumor. Dr. Matthew Scarpelli’s lab prioritizes development of molecular PET and MR imaging techniques that are sensitive to these effects and could be used as subjective measurements of immune response.

Area 3) Development of image-guided radio and immunotherapies. Dr. Scarpelli’s laboratory seeks to expand image-guidance in radiotherapy to include immunogenic targeting and adaptive therapy. This is accomplished through translational studies and collaborations with various medical centers.

Selected Publications:

Matthew Scarpelli, Healey DR, Mehta S, Kodibagkar VD, Quarles CC. A practical method for multimodal registration and assessment of whole-brain disease burden using PET, MRI, and optical imaging. Sci Rep. 2020, 10(1):17324. doi: 10.1038/s41598-020-74459-1

Matthew Scarpelli, Christopher Zahm, Scott Perlman, Douglas G. McNeel, Robert Jeraj and Glenn Liu. FLT PET/CT imaging of metastatic prostate cancer patients treated with pTVG-HP DNA vaccine and pembrolizumab. J Immunother Cancer. 2019, 7(1):23. doi: 10.1186/s40425-019-0516-1

Matthew Scarpelli, Urban Simoncic, Scott Perlman, Glenn Liu, and Robert Jeraj. Dynamic 18F-FLT PET imaging of spatiotemporal changes in tumor cell proliferation and vasculature reveals the mechanistic actions of anti-angiogenic therapy. Phys Med Biol. 2018, 63(15):155008. https://doi.org/10.1088/1361-6560/aad1be

Matthew Scarpelli, Jens Eickhoff, Enrique Cuna, Scott Perlman, Robert Jeraj, Optimal transformations leading to normal distributions of positron emission tomography standardized uptake values. Phys Med Biol. 2018, 63:035021. doi: 10.1088/1361-6560/aaa175

Yuting Lin, Stephen McMahon, Matthew Scarpelli, Harold Paganetti, Jan Schuemann. Comparing gold nano-particle enhanced radiotherapy with proton, megavoltage photons and kilovoltage photons: a monte carlo simulation. Phys Med Biol. 2014, 59:7675-7689. doi: 10.1088/0031-9155/59/24/7675